Synaptic degeneration in Alzheimer disease

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
• Key pathological hallmarks include amyloid-β and phosphorylated tau aggregates in the brain.
• Synaptic loss and degeneration are strongly correlated with cognitive impairment in AD.

Purpose of the Study:

• To elucidate the mechanisms underlying synaptic degeneration in Alzheimer disease.
• To identify critical questions for future research in AD synaptic pathology.
• To explore how understanding synaptic degeneration informs novel therapeutic strategies for AD.

Main Methods:

• Review of current literature on AD pathogenesis and synaptic dysfunction.
• Analysis of evidence linking soluble amyloid-β and tau to synaptotoxicity.
• Examination of glial cell roles in synapse engulfment and pathology spread.

Main Results:

• Soluble forms of amyloid-β and tau contribute to synaptotoxicity and spread via neural circuits.
• Altered glial cell phenotypes, including excessive synapse ingestion, are observed in AD.
• Synaptic degeneration is a central process driving cognitive decline in Alzheimer disease.

Conclusions:

• Understanding synaptic degeneration mechanisms is crucial for developing effective Alzheimer disease treatments.
• Further research is needed to fully address the complex processes of synaptic loss in AD.
• Investigating synaptic degeneration pathways offers promising avenues for novel therapeutic interventions.